You just read:

Imprimis Pharmaceuticals Patent-Pending Dropless and LessDrops Formulations Exceed One Million Patient Eyes Milestone

News provided by

Imprimis Pharmaceuticals, Inc.

Jul 27, 2017, 08:00 ET